Global Biochips Industry Growing at 18.6% CAGR to 2018 offers Analysis of Global Biochips Industry, 2012-2018 market research report that reviews the latest biochips market trends with a perceptive attempt to disclose the near-future growth prospects.

DALLAS, Oct. 9, 2013 /PRNewswire-iReach/ -- Analysis of Global Biochips Industry, 2012-2018 market research report forecasts the global biochips market to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major industry segments, biochips instruments are expected to exert the highest support to the industry with a CAGR of 20% globally. Microarrays segment accounts for nearly 70% of the industry value while services indicate lesser than15% of the market value. North America is expected to maintain the highest market share for the biochips industry by 2018; Asian economies are expected to post a large CAGR of 19 percent during 2012-2018. Higher growth rate favors improved industry investments in Asia-Pacific region in comparison with North America and Europe, going ahead.


Key Companies of the biochips market discussed and profiled in this report ( )  include: BD Biosciences, Clontech Laboratories Inc., Promega Corporation, Roche Nimblegen Inc., Mirus Bio Corporation, Hitachi Solutions America Ltd. (Miraibio Group), Perkinelmer Life Sciences, Genomic Solutions/Digilab Inc., Affymetrix Inc., Agilent Technologies, Applied Biosystems/Life Technologies Corporation, Qiagen N.V., Invitrogen/Life Technologies Corporation, Illumina Inc., Ambry Genetics Corp, Fluidigm Corporation, Combimatrix Corp, Biogenex, Folio Biosciences, Imgenex Corporation, Origene Technologies Inc., US Biomax Inc., Applied Microarrays Inc., Gentel Biosciences Inc., Wafergen Biosystems Inc., Positiveid Corporation, GE Healthcare / Amersham Biosciences, Eurofins Mwg Operon, Amgen, Microarrays Inc., Protagen AG,  Arrayjet Limited, Randox Laboratories Ltd, Siemens Medical Solutions, Eppendorf Array Technologies, Zeptosens AG, Affibody AB, Geneva Bioinformatics (Genebio) SA, Cytopathfinder Inc., Hokkaido System Science Co. Ltd., Hipep Laboratories, Lightarray™ Gene Technology Co. Ltd., Ocimum Biosolutions Ltd., Bioneer Corp., Petagen Inc., Diversity Arrays Technology Pty Ltd, Benitec Limited and Dr. Chip Biotechnology Inc.

This research, available for purchase at , provides an in-depth analysis on a geographic basis that offers strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations. The report primarily focuses on:

  • Emerging Market Trends
  • Advancements in the Technological Space
  • Market Demand Of The Segments (By-Region)
  • Key Growth Areas and Market Size
  • Region-Wise Demand Factor
  • Key Competitors Edge
  • Investment Strategies

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the biochips industry.The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
The analysis primarily deals with products, applications and technologies. Further, the subdivided categories include:

Biochips - By Segment

  • Microarrays
  • By Type
  • DNA Biochips
  • Lab-on-Chips
  • Protein Biochips
  • Tissue Microarray
  • Others
  • Cell-on Chips
  • Organ-on-Chips
  • Human-on-Chips
  • By Technology
  • Gene Expression
  • SNP Identification
  • High Throughput Screening
  • Proteomics

Biochip Related Products

  • Instruments
  • Reagents and Consumables
  • Software
  • Services
  • Biochips - By Application
  • Drug Discovery and Development
  • Diagnostics and Treatment
  • Research
  • Forensic
  • Other (Agriculture, Environmental Sensors, Food Inspection)

The period considered for the biochips market analysis is 2012-2018. The region wise distribution of the market consists of North America (USA and Canada), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific), Europe (Germany, France, United Kingdom, Italy, Spain, Russia and Rest of Europe), and Rest of the World.

More than 640 leading market players are identified and 48 key companies that project improved market activities in the near future are profiled. The report consists of 165 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

The evolution of biochips has opened new vistas in the biological systems. In addition, all other sciences are integrated which cumulatively contribute for a big future of biochip industry. The broad 'life science' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the biochips industry, even during the recession years, confirms the positive growth prospects going ahead. The field of drug discovery and development research gets more glamorous with the diagnostics and treatment at cellular level. DNA biochips and lab-on-chips have created revolution enabling the target validation. Genome scan is very soon going to become an ultimate weapon for diagnosis. In no time all the information related to genes will be sequenced, annotated and completed along with the list of diseases which are susceptible. Day to day the researchers are also making an effort to develop medication to control the various diseases, by using biochip technology. As the applications of biochips are wide both in the research and clinical use, a wide potential market is expected. The emergence of biochip technology can be attributed to a decade which has gradually developed into maturity. This industry is expected to bring rapid and significant changes in the life sciences and medicine. Microarray technologies have a great potential and is widely used in DNA and protein analysis.

Comprehensive Table of Contents with a detailed list of Tables provided in the Analysis of Global Biochips Industry, 2012-2018 report is available at .

Explore more reports on the biotechnology industry at .

About Us: is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. Call +1 888 391 5441 with your research requirements.

Media Contact: Priyank Tiwari,, +1 888 391 5441,

News distributed by PR Newswire iReach:




Computer Electronics, Publishing & Information Services, Health Care & Hospitals, Surveys, Polls and Research

Need Help